Effects of Methylprednisolone on Bone Mineral Density and Microarchitecture of Trabecular Bones in Rats with Administration Time and Assessed by Micro-Computed Tomography

References

• Clowes JA, Peel N, Eastell R. Glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 2001; 13: 326–32
   PubMed Web of Science ®Google Scholar
• Kaji H, Yamauchi M, Chihara K, Sugimoto T. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis. Endocr J 2006; 53: 27–34
   PubMed Web of Science ®Google Scholar
• Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res 2006; 21: 466–76
   PubMed Web of Science ®Google Scholar
• Balooch G, Yao W, Ager JW, Balooch M, Nalla RK, Porter AE, et al. The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids. Arthritis Rheum 2007; 56: 3726–37
   PubMed Web of Science ®Google Scholar
• Tanaka I, Oshima H. Glucocorticoid-induced osteoporosis and bone mineral densimetry. Clin Calcium 2004; 14: 77–82
   PubMedGoogle Scholar
• McLaughlin F, Mackintosh J, Hayes BP, McLaren A, Uings IJ, Salmon P, et al. Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers. Bone 2002; 30: 924–30
   PubMed Web of Science ®Google Scholar
• Eberhardt AW, Yeager-Jones A, Blair HC. Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid-treated rabbits. Endocrinology 2001; 142: 1333–40
   PubMed Web of Science ®Google Scholar
• Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 2001; 16: 97–103
   PubMed Web of Science ®Google Scholar
• Hulley PA, Conradie MM, Langeveldt CR, Hough FS. Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate. Bone 2002; 31: 220–9
   PubMed Web of Science ®Google Scholar
• McErlain DD, Chhem RK, Bohay RN, Holdsworth DW. Micro-computed tomography of a 500-year-old tooth: technical note. Can Assoc Radiol J 2004; 55: 242–5
   PubMed Web of Science ®Google Scholar
• Tommasini SM, Morgan TG, van der Meulen MCh, Jepsen KJ. Genetic variation in structure-function relationships for the inbred mouse lumbar vertebral body. J Bone Miner Res 2005; 20: 817–27
   PubMed Web of Science ®Google Scholar
• Hildebrand T, Rüegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Engin 1997; 1: 15–23
   PubMedGoogle Scholar
• Du LY, Umoh J, Nikolov HN, Pollmann SI, Lee TY, Holdsworth DW. A quality assurance phantom for the performance evaluation of volumetric micro-CT systems. Phys Med Biol 2007; 52: 7087–108
   PubMed Web of Science ®Google Scholar
• Chappard D, Retailleau-Gaborit N, Legrand E, Baslé MF, Audran M. Comparison insight bone measurements by histomorphometry and microCT. J Bone Miner Res 2005; 20: 1177–84
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhao J, Liao EY, Dai RC, Wu XP, Genant HK. Application of micro-CT assessment of 3-D bone microstructure in preclinical and clinical studies. J Bone Miner Metab 2005; 23(Suppl)122–31
   PubMed Web of Science ®Google Scholar
• Feldkamp LA, Goldstein SA, Parfitt AM, Jesion G, Kleerekoper M. The direct examination of three-dimensional bone architecture in vitro by computed tomography. J Bone Miner Res 1989; 4: 3–11
   PubMed Web of Science ®Google Scholar
• Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, et al. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial. Arch Intern Med 2007; 167: 591–6
   PubMed Web of Science ®Google Scholar
• Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 2001; 16: 97–103
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhao J, Genant HK, Dequeker J, Geusens P. Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats. J Bone Miner Res 1997; 12: 820–31
   PubMed Web of Science ®Google Scholar
• Maricic M, Gluck O. Densitometry in glucocorticoid-induced osteoporosis. J Clin Densitom 2004; 7: 359–63
   PubMed Web of Science ®Google Scholar
• Sohen S. Bone quality in glucocorticoid induced osteoporosis. Clin Calcium 2004; 4: 568–72
   Google Scholar
• Yang J, Pham SM, Crabbe DL. High-resolution micro-CT evaluation of mid- to long-term effects of estrogen deficiency on rat trabecular bone. Acad Radiol 2003; 10: 1153–8
   PubMed Web of Science ®Google Scholar
• Frost HM. On the trabecular “thickness”-number problem. J Bone Miner Res 1999; 14: 1816–21
   PubMed Web of Science ®Google Scholar
• Frost HM. A 2003 update of bone physiology and Wolff's law for clinicians. Angle Orthod 2004; 74: 3–15
   PubMed Web of Science ®Google Scholar
• Takahashi M, Saha PK, Wehrli FW. Skeletal effects of short-term exposure to dexamethasone and response to risedronate treatment studied in vivo in rabbits by magnetic resonance micro-imaging and spectroscopy. J Bone Miner Metab 2006; 24: 467–75
   PubMed Web of Science ®Google Scholar
• Sheng ZF, Dai RC, Wu XP, Fang LN, Fan HJ, Liao EY. Regionally specific compensation for bone loss in the tibial trabeculae of estrogen-deficient rats. Acta Radiol 2007; 48: 531–9
   PubMed Web of Science ®Google Scholar